Empowering women in human immunodeficiency virus prevention

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 26, Issue 4, 2012, Pages 487-493

  Abdool Karim, Quarraisha ^a,b   Humphries, Hilton ^b   Stein, Zena ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

HIV; microbicides; prevention; women

Indexed keywords

ANTIRETROVIRUS AGENT; BIOLOGICAL FACTOR; CONTRACEPTIVE AGENT; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; ERDOSTEINE; MICROBICIDE; PRO 2000; TENOFOVIR;

ABSTINENCE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADVERSE OUTCOME; ATTITUDE TO HEALTH; BIRTH CONTROL; BLOOD TRANSFUSION; BREAST FEEDING; CIRCUMCISION; CLINICAL EFFECTIVENESS; CLINICAL TRIAL (TOPIC); CONDOM; CONTRACEPTION; CULTURAL FACTOR; DISEASE FREE SURVIVAL; EARLY DIAGNOSIS; EPIDEMIC; FAMILY PLANNING; FEMALE; FEMALE FERTILITY; GEL; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH PROGRAM; HEALTH SERVICE; HETEROSEXUAL MALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT MORTALITY; LIFE EXPECTANCY; MALE HOMOSEXUAL; MATERNAL MORTALITY; MEDICAL EDUCATION; MEDICAL INFORMATION SYSTEM; MONOGAMY; PANDEMIC; POLITICS; PREGNANT WOMAN; PRIORITY JOURNAL; REPRODUCTIVE HEALTH; REVIEW; RISK; SEXUAL HEALTH; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; TUBERCULOSIS; UNITED STATES; UNWANTED PREGNANCY; UTERINE CERVIX CAP; VIRUS TRANSMISSION;

EID: 84862855559     PISSN: 15216934     EISSN: 15321932     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2012.01.006     Document Type: Article

References (52)

1. UNAIDS, WHO. AIDS epidemic update. In: Geneva: Joint United Nations Programme on HIV/AIDS and World Health Organization 2010.
2. *Abdool Karim SS, Churchyard GJ, Abdool Karim Q et al. HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet 2009; 374: 921-933.
3. Abdool Karim Q, Sibeko S & Baxter C. Preventing HIV infection in women: a global health imperative!. Clin Infect Dis 2010; 50(Suppl. 3): S122-S129.
4. *Karim QA, Kharsany ABM, Frohlich JA et al. Stabilizing HIV prevalence masks high HIV incidence rates amongst rural and urban women in KwaZulu-Natal, South Africa. Int J Epidemiol 2011; 40: 922-930.
5. Ramjee G, Karim SS & Sturm AW. Sexually transmitted infections among sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 1998; 25: 346-349. (Pubitemid 28368945)
6. Gregson SCA, Nyamukapa GP, Garnett GP et al. Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe. Lancet 2002; 359: 1896-1903. (Pubitemid 34615768)
7. *Pettifor AE, Rees HV, Kleinschimidt I et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005; 19: 1525-1534. (Pubitemid 41400699)
8. Bobat R, Moodley D, Coutsoudis A et al. Breastfeeding by HIV-1-infected women and outcome in their infants: a cohort study from Durban, South Africa. AIDS 1997; 11: 1627-1633. (Pubitemid 27460253)
9. Guay LA, Musoke P, Fleming T et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999; 354: 795-802. (Pubitemid 29415583)
10. Abdool-Karim Q, AbouZahrb C, Dehne K et al. HIV and maternal mortality: turning the tide. Lancet 2010; 375: 1948-1949.
11. *Moodley J, Pattinson R, Baxter C et al. Strengthening HIV services for pregnant women: an opportunity to reduce maternal mortality rates in Southern Africa/sub-Saharan Africa. BJOG 2011; 118: 219-225.
12. Bradshaw D, Nannan N, Laubscher R et al. South African national burden of disease study 2000: estimates of provincial mortality: summary report. Parow: Medical Research Council, 2006.
13. *Padian NS, McCoy SI, Balkus JE et al. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS 2010; 24: 621-635.
14. *Karim SS & Karim QA. Antiretroviral prophylaxis: a defining moment in HIV control. Lancet 2011; 378: e23-e25.
15. Fauci AS. AIDS: let science inform policy. Science 2011; 333: 13.
16. *Abdool Karim Q, Abdool Karim SS, Frohlich JA et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV Infection in women. Science 2010; 329: 1168-1174.
17. *Patterson K, Prince H, Kraft E et al. Exposure of extracellular and intracellular tenofovir and emtricitabine in mucosal tissues after a single fixed dose of TDF/FTC: implications for pre-exposure HIV prophylaxis (PrEP). XVIII International AIDS Conference 2010., Vienna, Austria.
18. Thigpen MC, Kebaabetswe PM, Smith DK et al. Daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana: results from the TDF2 Study. Abstract WELBC01. 6th IAS Conference. Rome 2011.
19. FHI. FEM-PrEP Project; http://www.fhi.org/en/Research/Projects/FEM-PrEP. htm [last accessed 20.01.12].
20. MTN. Update on VOICE; http://www.mtnstopshiv.org/node/3623 [last accessed 20.01.12].
21. Cates Jr. W & Holmes KK. Condom efficacy against gonorrhea and nongonococcal urethritis (letter). Am J Epidemiol 1996; 143: 843-844.
22. Ehrhardt AA. Preventing and treating AIDS: the expertise of the behavioral sciences. Bull NY Acad Med 1988; 64: 513-519.
23. Flam R & Stein ZA. Behavior, infection and immune response: an epidemiological approach. In Feldman & Johnson (eds.). The social dimension of AIDS: methods and theory. Wesport CT: Praeger Press, 1986, pp. 61-76.
24. Smith DK, Warren DL, Vlahov D et al. for the Human Immunodeficiency Virus Epidemiology Research Study Group. Design and baseline participant characteristics of the Human Immunodeficiency Virus pidemiology Research (HER) Study: a prospective cohort study of human immunodeficiency virus infection in US women. Am J Epidemiol 1997; 146: 459-469. (Pubitemid 27391406)
25. Skovdal M, Campbell C, Madanhire C et al. When masculinity interferes with women's treatment of HIV infection: a qualitative study about adherence to antiretroviral therapy in Zimbabwe. J Int AIDS Soc 2011; 7: 13.
26. Denis P, Becker C. The HIV/AIDS epidemic in sub-Saharan Africa in a historical perspective; http://rds.refer.sn/IMG/pdf/AIDSHISTORYALL.pdf [last accessed 20.01.12].
27. Temmerman M, Quaghebeura A, Mwanyumba F et al. Mother-to-child HIV transmission in resource poor settings: how to improve coverage? AIDS 2003; 17: 1239-1242. (Pubitemid 36667765)
28. Maman S, Mbwambo JK, Hogan N et al. High rates and positive outcomes of HIV-serostatus disclosure to sexual partners: reasons for cautious optimism from a voluntary counseling and testing clinic in Dar es Salaam, Tanzania. AIDS Behav 2003; 7: 373-382. (Pubitemid 38005000)
29. Siedel G, Sewpaul V & Dano B. Experiences of breastfeeding and vulnerability among a group of HIV-positive women in Durban, South Africa. Health Policy Plan 2000; 15: 24-33. (Pubitemid 30137882)
30. Myer L, Morroni C, Mathews C et al. Dual method use in South Africa. Int Fam Plan Perspect 2002; 28: 119-121.
31. Worth D. Sexual decision-making and AIDS: why condom promotion among vulnerable women is likely to fail. Stud Fam Plann 1989; 20: 297-307.
32. International Centre for Research on women; http://www.icrw.org/ [last accessed 20.01.12].
33. Abdool Karim Q, Abdool Karim SS & Nkomokazi J. Sexual behaviour and knowledge of AIDS among urban black mothers. Implications for AIDS intervention programmes. S Afr Med J 1991; 80: 340-343.
34. Ehrhardt AA, Wasserheit JN. Age, gender and sexual risk behaviours for sexually transmitted diseases in the US. In: Wasserheit JN, Aral SO, Holmes KK, et al., eds. Research issues in human behaviour and sexually transmitted diseases in the AIDS era. Washington, DC: American Society for Microbiology; 1991; pp. 97-121.
35. *Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990; 80: 460-462. (Pubitemid 20105954)
36. Global Campaign for Microbicides; http://www.global-campaign.org/mission. htm [last accessed 20.01.12].
37. Interview with Polly Harrison. The past, present and future of HIV microbicide research advocacy. Tagline 2011; 18:
38. Feldblum P, Adeiga A, Bakare R et al. SAVVY vaginal gel (C31G) for prevention of HIV infection: A randomized controlled trial in Nigeria. PLosOne 2008; 3: e1471.
39. Roddy RE, Zekeng L, Ryan KA et al. A controlled trial of nonoxynol 9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-510. (Pubitemid 28384883)
40. CONRAD. http://www.conrad.org/microbicides.html [last accessed 20.01.12].
41. Gupta GR, Weiss E & Whelan D. Male-female inequalities result in submission to high-risk sex in many societies. Special report: women and HIV. AIDS Anal Afr 1995; 5: 8-9.
42. Karim, SSA. Microbicides for the prevention of HIV Infection. 2nd South African AIDS Conference in Durban, South Africa 2005; 30-40.
43. van Damme L, Ramjee G, Alary M et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360: 971-977. (Pubitemid 35284107)
44. Press release about CONRAD Funding for microbicide development. http://www.evms.edu/about-evms-news/Page-37.html [last accessed 2.01.12].
45. USAID. Final report USAID microbicide stakeholders meeting 29 November 2010, Washington, DC; http://www.usaid.gov/our-work/global-health/aids/ TechAreas/research/final-report-microbicide-meeting112910.pdf [last accessed 21.01.12].
46. Carballo-Diéguez A, Stein Z, Saez H et al. Frequent use of lubricants for anal sex among men who have sex with men: the HIV prevention potential of a microbicidal gel. Am J Public Health 2000; 90: 1117-1121. (Pubitemid 30445367)
47. Female Health Company; http://www.femalehealth.com/ [last accessed 20.01.12].
48. Barbosa RM, Kalckmann S, Berquo E et al. Notes on the female condom: experiences in Brazil. Int J STD and AIDS 2007; 18: 261-266. (Pubitemid 351739028)
49. Auvert B, Taljaard D, Largarde E et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLos Med 2005; 2: e298.
50. Bailey RC, Moses S, Parker CB et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369: 643-656. (Pubitemid 46281312)
51. Gray RH, Kigozi G, Serwadda D et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369: 657-666.
52. *Cates Jr. W, Abdool Karim Q, El-Sadr W et al. Global development. Family planning the Millennium Development Goals. Science 2010; 329: 1603.